The effect of sertindole on QTD and TPTE

被引:29
作者
Nielsen, J. [1 ]
Andersen, M. P. [2 ]
Graff, C. [2 ]
Kanters, J. K. [3 ,4 ]
Hardahl, T. [2 ]
Dybbro, J. [5 ]
Struijk, J. J. [2 ]
Meyer, J. M. [6 ]
Toft, E. [2 ]
机构
[1] Aarhus Univ Hosp, Unit Psychiat Res, Aalborg Psychiat Hosp, DK-9100 Aalborg, Denmark
[2] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark
[3] Gentofte Univ Hosp, Dept Cardiol P, Gentofte, Denmark
[4] Univ Copenhagen, Lab Expt Cardiol, Ctr Cardiac Arrhythmia DARC, Danish Natl Res Fdn, Copenhagen, Denmark
[5] Aarhus Univ Hosp, Dept Psychiat, Psychiat Hosp Risskov, Aarhus, Denmark
[6] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
关键词
QT dispersion; sertindole; Tpeak-Tend; QTc; sudden death; torsade de pointes; DE-POINTES; DISPERSION; SURVEILLANCE; SAFETY; RISK;
D O I
10.1111/j.1600-0447.2009.01534.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Recent research suggests that other surrogate markers than QTc, including QTc dispersion and Tpeak-Tend, may better correlate with cardiac arrhythmia risk. While sertindole significantly prolongs the QTc interval, the effects on other markers of arrhythmia risk, such as QTc dispersion and Tpeak-Tend are unknown. Method: Digital 12-lead ECG was recorded at baseline and at steady-state in 37 patients switched to sertindole. ECG was analysed for Fridericia-corrected QT duration (QTcF), QT dispersion and Tpeak-Tend. Results: From a baseline QTcF of 407 +/- 22 ms, mean QTcF prolongation during sertindole treatment was 20 +/- 23 ms, P < 0.01. No effect on QTc dispersion was found (-1 +/- 11 ms; P = 0.41). No increased duration of the Tpeak-Tend interval from baseline was found (+7 +/- 21 ms; P = 0.05). Conclusion: These findings might be related to the absence of confirmed Torsade de Pointes (TdP) cases related to sertindole exposure, despite sertindole's QTc prolonging effects.
引用
收藏
页码:385 / 388
页数:4
相关论文
共 15 条
[1]   Investigating the Role of Ventricular Repolarization Morphology in Surface ECGs for Identifying Patients with a History of Drug-Induced Arrhythmias [J].
Coudere, J. P. ;
Kaab, S. ;
Hinterseer, M. ;
McNitt, S. ;
Xia, X. ;
Fossa, A. ;
Beckmann, B. ;
Polonsky, S. ;
Zareba, W. .
COMPUTERS IN CARDIOLOGY 2007, VOL 34, 2007, 34 :337-+
[2]   Sertindole: cardiac electrophysiological profile [J].
Haverkamp, W ;
Eckardt, L ;
Matz, J ;
Frederiksen, K .
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 :S11-S20
[3]   Proarrhythmia with class III antiarrhythmic drugs: Types, risks, and management [J].
Hohnloser, SH .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 :G82-G89
[4]   Measurement error as a source of QT dispersion: a computerised analysis [J].
Kors, JA ;
van Herpen, G .
HEART, 1998, 80 (05) :453-458
[5]   QT Dispersion: Still a Useful Measurement [J].
Molnar, Janos ;
Somberg, John C. .
CARDIOLOGY, 2009, 112 (03) :165-167
[6]   Biases affecting the proportional reporting ratio (PRR) in spontaneous reports pharmacovigilance databases: the example of sertindole [J].
Moore, N ;
Hall, G ;
Sturkenboom, M ;
Mann, R ;
Lagnaoui, R ;
Begaud, B .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (04) :271-281
[7]   Sertindole causes distinct electrocardiographic T-wave morphology changes [J].
Nielsen, Jimmi ;
Graff, Claus ;
Hardahl, Thomas ;
Andersen, Mads P. ;
Kristoffersen, Jens ;
Struijk, Johannes J. ;
Toft, Egon ;
Meyer, Jonathan M. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (10) :702-707
[8]   The European sertindole safety and exposure survey: a follow-up study of 8600 patients [J].
Peuskens, Joseph ;
Moore, Nicholas ;
Azorin, Jean-Michel ;
Toumi, Mondher ;
Cochran, John .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (07) :804-811
[9]   Efficacy, cardiac safety and tolerability of sertindole:: a drug surveillance [J].
Pezawas, L ;
Quiner, S ;
Moertl, D ;
Tauscher, J ;
Barnas, C ;
Küfferle, B ;
Wolf, R ;
Kasper, S .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (04) :207-214
[10]   Comparative reproducibility of QT, QT peak, and T peak T end intervals and dispersion in normal subjects, patients with myocardial infarction, and patients with hypertrophic cardiomyopathy [J].
Savelieva, I ;
Yap, YG ;
Yi, G ;
Guo, XH ;
Camm, AJ ;
Malik, M .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (11) :2376-2381